Two Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids

The global health emergency for SARS-CoV-2 (COVID-19) created an urgent need to develop new treatments and therapeutic drugs. In this study, we tested, for the first time on human cells, a new tetravalent neutralizing antibody (15033-7) targeting Spike protein and a synthetic peptide homologous to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Spitalieri, Paola, Centofanti, Federica, Murdocca, Michela, Scioli, Maria Giovanna, Latini, Andrea, Di Cesare, Silvia, Citro, Gennaro, Rossi, Antonio, Orlandi, Augusto, Miersch, Shane, Sidhu, Sachdev S., Pandolfi, Pier Paolo, Botta, Annalisa, Sangiuolo, Federica, Novelli, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997767/
https://www.ncbi.nlm.nih.gov/pubmed/35406799
http://dx.doi.org/10.3390/cells11071235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997767/
https://www.ncbi.nlm.nih.gov/pubmed/35406799
http://dx.doi.org/10.3390/cells11071235

Ejemplares similares